Severe sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report

• Päätekijät: Meng Xu (Tekijä), Congcong Liu (Tekijä), Lishuang Guo (Tekijä), Sirui Yang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2020-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Interleukin (IL)-6 plays an essential role in the pathogenesis of systemic juvenile idiopathic arthritis (sJIA). Tocilizumab (TCZ), a kind of biological agent against both membrane and soluble IL-6 receptor, is the only biological agent approved for the treatment of sJIA in China...